PDS Biotechnology (PDSB) Liabilities and Shareholders Equity (2014 - 2026)
PDS Biotechnology's Liabilities and Shareholders Equity came in at $8.81 million for Q2 2026, down 78.2% from $40.48 million a year earlier.
Powered by 
Analysis
PDS Biotechnology (PDSB) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends
At the end of FY2025, PDS Biotechnology's Liabilities and Shareholders Equity was $30.49 million, down 32.8% from FY2024.
- Liabilities and Shareholders Equity has declined in each of the last three years, with a five-year compound annual growth rate of -0.3% (FY2020 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $45.36 million in FY2024 (-23.6%), $59.39 million in FY2023 (-22.9%), $77.01 million in FY2022 (+14.6%) and $67.2 million in FY2021 (+117.5%).
- The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity since Q4 2018.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2022 (growth of 119.9%), and the weakest in Q2 2026 (a decline of 78.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | PDS Biotechnology | 41.94 Mn | 41.94 Mn | - | 8.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.81 Mn |
| Dec 31, 2025 | 30.49 Mn |
| Sep 30, 2025 | 34.71 Mn |
| Jun 30, 2025 | 40.48 Mn |
| Mar 31, 2025 | 47.03 Mn |
| Dec 31, 2024 | 45.36 Mn |
| Sep 30, 2024 | 52.45 Mn |
| Jun 30, 2024 | 60.50 Mn |
| Mar 31, 2024 | 69.01 Mn |
| Dec 31, 2023 | 59.39 Mn |
| Sep 30, 2023 | 57.19 Mn |
| Jun 30, 2023 | 63.75 Mn |
| Mar 31, 2023 | 68.45 Mn |
| Dec 31, 2022 | 77.01 Mn |
| Sep 30, 2022 | 74.89 Mn |
| Jun 30, 2022 | 56.00 Mn |
| Mar 31, 2022 | 61.04 Mn |
| Dec 31, 2021 | 67.20 Mn |
| Sep 30, 2021 | 71.75 Mn |
| Jun 30, 2021 | 77.39 Mn |
API Access
PDS Biotechnology Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();